A new study in the Journal of Alzheimer's Disease shows that semaglutide, a diabetes drug, may cut the risk of Alzheimer's-related dementias in people with type 2 diabetes. Researchers looked at data from over 1.7 million patients and found a strong link, suggesting semaglutide may protect the brain, not just control blood sugar.